Published in

Wiley, Pharmacoepidemiology & Drug Safety, 8(29), p. 825-831, 2020

DOI: 10.1002/pds.5029

Links

Tools

Export citation

Search in Google Scholar

Considerations for pharmacoepidemiological analyses in the SARS‐CoV‐2 pandemic#

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO